Terms: = Kidney tumors AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521
52 results:
1. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
Rogala J; Zhou M
Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
[TBL] [Abstract] [Full Text] [Related]
2. CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (
Grand-Guillaume J; Mansi R; Gaonkar RH; Zanger S; Fani M; Eugster PJ; Beck Popovic M; Grouzmann E; Abid K
J Transl Med; 2023 Sep; 21(1):604. PubMed ID: 37679770
[TBL] [Abstract] [Full Text] [Related]
3. Functional recovery after partial nephrectomy: next generation analysis.
Munoz-Lopez C; Lewis K; Attawettayanon W; Yasuda Y; Emrich Accioly JP; Rathi N; Lone Z; Boumitri M; Campbell RA; Wood A; Kaouk JH; Haber GP; Eltemamy M; Krishnamurthi V; Abouassaly R; Haywood SC; Weight CJ; Campbell SC
BJU Int; 2023 Aug; 132(2):202-209. PubMed ID: 37017637
[TBL] [Abstract] [Full Text] [Related]
4. kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP).
Ricketts CJ; Killian JK; Vocke CD; Wang Y; Merino MJ; Meltzer PS; Linehan WM
PLoS One; 2022; 17(12):e0278108. PubMed ID: 36455002
[TBL] [Abstract] [Full Text] [Related]
5. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Pheochromocytoma and Paraganglioma.
Fuchs TL; Luxford C; Clarkson A; Sheen A; Sioson L; Elston M; Croxson MS; Dwight T; Benn DE; Tacon L; Field M; Ahadi MS; Chou A; Clifton-Bligh RJ; Gill AJ
Am J Surg Pathol; 2023 Jan; 47(1):25-36. PubMed ID: 35993574
[TBL] [Abstract] [Full Text] [Related]
6. Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.
Aggarwal RK; Luchtel RA; Machha V; Tischer A; Zou Y; Pradhan K; Ashai N; Ramachandra N; Albanese JM; Yang JI; Wang X; Aluri S; Gordon S; Aboumohamed A; Gartrell BA; Hafizi S; Pullman J; Shenoy N
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34551979
[TBL] [Abstract] [Full Text] [Related]
7. Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma.
Kamai T; Higashi S; Murakami S; Arai K; Namatame T; Kijima T; Abe H; Jamiyan T; Ishida K; Shirataki H; Yoshida KI
Cancer Sci; 2021 Aug; 112(8):3375-3387. PubMed ID: 34014604
[TBL] [Abstract] [Full Text] [Related]
8. Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.
Zhou J; Singh P; Yin K; Wang J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Lubitz CC; Hughes KS
Ann Surg Oncol; 2021 Oct; 28(11):6590-6600. PubMed ID: 33660127
[TBL] [Abstract] [Full Text] [Related]
9. False Positive of
Zampetti B; Attanasio R; Boniardi M; Cozzi R
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1352-1355. PubMed ID: 32955005
[TBL] [Abstract] [Full Text] [Related]
10. A rare serious case of retroperitoneal paraganglioma misdiagnosed as duodenal gastrointestinal stromal tumor: a case report.
Mahmoud S; Salami M; Salman H
BMC Surg; 2020 Mar; 20(1):49. PubMed ID: 32178651
[TBL] [Abstract] [Full Text] [Related]
11. Malignant Intrarenal/Renal Pelvis Paraganglioma with Co-Occurring SDHB and ATRX Mutations.
Irwin T; Konnick EQ; Tretiakova MS
Endocr Pathol; 2019 Dec; 30(4):270-275. PubMed ID: 31705439
[TBL] [Abstract] [Full Text] [Related]
12. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
[TBL] [Abstract] [Full Text] [Related]
13. Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.
Stein J; Tenbrock J; Kristiansen G; Müller SC; Ellinger J
Int J Urol; 2019 Sep; 26(9):910-916. PubMed ID: 31280487
[TBL] [Abstract] [Full Text] [Related]
14. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.
Eijkelenkamp K; Osinga TE; Links TP; van der Horst-Schrivers ANA
Clin Genet; 2020 Jan; 97(1):39-53. PubMed ID: 30977114
[TBL] [Abstract] [Full Text] [Related]
15. SDH-deficient renal cell carcinoma - clinical, pathologic and genetic correlates: a case report.
Kumar R; Bonert M; Naqvi A; Zbuk K; Kapoor A
BMC Urol; 2018 Nov; 18(1):109. PubMed ID: 30482207
[TBL] [Abstract] [Full Text] [Related]
16. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor With SDHC Germline Mutation and Bilateral Renal and Neck Cysts.
Stanley K; Friehling E; Davis A; Ranganathan S
Pediatr Dev Pathol; 2019; 22(3):265-268. PubMed ID: 30301441
[TBL] [Abstract] [Full Text] [Related]
17. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
Wang G; Rao P
Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
[TBL] [Abstract] [Full Text] [Related]
18. Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.
Casey RT; Warren AY; Martin JE; Challis BG; Rattenberry E; Whitworth J; Andrews KA; Roberts T; Clark GR; West H; Smith PS; Docquier FM; Rodger F; Murray V; Simpson HL; Wallis Y; Giger O; Tran M; Tomkins S; Stewart GD; Park SM; Woodward ER; Maher ER
J Clin Endocrinol Metab; 2017 Nov; 102(11):4013-4022. PubMed ID: 28973655
[TBL] [Abstract] [Full Text] [Related]
19. HIF-2alpha: Achilles' heel of pseudohypoxic subtype paraganglioma and other related conditions.
Tella SH; Taïeb D; Pacak K
Eur J Cancer; 2017 Nov; 86():1-4. PubMed ID: 28946040
[TBL] [Abstract] [Full Text] [Related]
20. DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: beyond pheochromocytomas and paragangliomas.
Mannelli M; Canu L; Ercolino T; Rapizzi E; Martinelli S; Parenti G; De Filpo G; Nesi G
Eur J Endocrinol; 2018 Jan; 178(1):R11-R17. PubMed ID: 28924001
[TBL] [Abstract] [Full Text] [Related]
[Next]